Suresh H. Moolgavkar

Biography

 Dr. Moolgavkar has more than 30 years of experience in the fields of epidemiology, biostatistics, and quantitative risk assessment. He is internationally known for his work in developing mechanistically based dose-response models for carcinogenesis, and, in particular, for the two-mutation clonal expansion model, also known as the Moolgavkar-Venzon-Knudson (MVK) model. Dr. Moolgavkar has also been keenly interested in air pollution epidemiology and has published on the impact of criteria pollutants, including fine PM and ozone, on human health.  Dr. Moolgavkar retired from his position at the Fred Hutchinson Cancer Research Center in August 2015, and assumed the position of Emeritus Member. At the same time, he retired from his positions as Professor of Epidemiology and Adjunct Professor of Applied Mathematics at the University of Washington. Dr. Moolgavkar has served on the faculties of the Johns Hopkins University, the Indiana University, the University of Pennsylvania, and the Fox Chase Cancer Center. He has been a visiting scientist at the Radiation Effects Research Foundation in Hiroshima, the International Agency for Research on Cancer in Lyon, and the German Cancer Research Center in Heidelberg. Dr. Moolgavkar has served on numerous review panels and as a consultant to the National Cancer Institute, EPA, Health and Welfare, Canada, the International Agency for Research on Cancer (IARC), the California Air Resources Board (CARB), and the CIIT Centers for Health Research, among others. Dr. Moolgavkar is the author or co-author of more than 180 papers and contributed chapters in the areas of epidemiology, biostatistics, and quantitative risk assessment, and has edited three books in these areas. He was the senior editor of a monograph, Quantitative Estimation and Prediction of Human Cancer Risk, published by the International Agency for Research on Cancer. He is an elected member of the American Epidemiological Society. Dr. Moolgavkar has served on the editorial boards of Genetic Epidemiology and Inhalation Toxicology. In 2012, he stepped down from his position as an Associate Editor of Risk Analysis — An International Journal, but continues to serve on the editorial board. Dr. Moolgavkar has published numerous epidemiological and toxicological papers on lung cancer, including lung cancer associated with smoking, radiation, diesel exhaust emissions and exposure to fibers, including asbestos. Dr. Moolgavkar was a member of the working group involved in the writing of the IARC monograph on tobacco smoking in 1986 (IARC monograph 38).  Dr. Moolgavkar was given the Founders' Award by the CIIT Centers for Health Research in 1990, the Distinguished Achievement Award by the Society for Risk Analysis (SRA) in 2001 and the Outstanding Service Award by SRA in 2012. He is one of a few members of SRA to have received both the Distinguished Achievement and Outstanding Service Awards. He is a Fellow of SRA, the pre-eminent international scientific society for risk assessment.  Dr. Moolgavkar's research has been supported largely by grants from the National Institutes of Health, the U.S. Department of Energy, and EPA. 

Research Interest

 Epidemiology & Computational Biology